Results 181 to 190 of about 150,260 (318)
A skin lesion after cardiac catheterization [PDF]
Alaminos, Miguel +6 more
core +2 more sources
Steroid‐Induced Takotsubo Cardiomyopathy in a Patient With Immune Thrombocytopenic Purpura
ABSTRACT This case report highlights a temporal relationship between dexamethasone administration and the onset of Takotsubo cardiomyopathy, underscoring the importance of recognizing pharmacologic agents as potential non‐traditional triggers, particularly in patients with underlying cardiovascular disease and no identifiable emotional or physical ...
Qutaiba Qafisheh +8 more
wiley +1 more source
A case of Henoch-Schönlein purpura associated with tick exposure. [PDF]
Randrianarisoa RMF +3 more
europepmc +1 more source
A Metabolic Study of a Patient with Idiopathic Cyclical Thrombocytopenic Purpura [PDF]
William A. Skoog +2 more
openalex +1 more source
Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom [PDF]
, +4 more
core +1 more source
A Novel Homozygous GFI1B Mutation in Siblings With Thrombocytopenia and Bleeding Tendency
Pedigree chart showing affected siblings. ABSTRACT Platelet type bleeding disorder 17 (OMIM #187900) is a type of “gray platelet syndrome” and occurs due to a mutation in the GFI1B gene on chromosome 9q34.13. Patients usually present with a history of easy bleeding tendencies, recurrent epistaxis or gum bleeding, and rarely with severe hemorrhage, and ...
Shova Aryal +3 more
wiley +1 more source
IgA Vasculitis Across the Ages: Is It Time for a Precision Medicine Approach? [PDF]
Gage A +4 more
europepmc +1 more source
Management of Gaucher Disease Type 1 in a Resource‐Limited Setting: A Pediatric Case Study
ABSTRACT This case report depicts the management of an 8‐year‐old male with Gaucher Disease Type 1, manifesting as massive splenomegaly, anemia, and skeletal involvement in a resource‐constrained environment. Treated with splenectomy due to the absence of enzyme replacement therapy, it underscores the necessity for enhanced therapeutic access and ...
Bipesh Kumar Shah +4 more
wiley +1 more source

